Atossa Therapeutics (ATOS) Enterprise Value (2012 - 2026)
Atossa Therapeutics (ATOS) reported Enterprise Value of -$6.84 million for Q2 2026, compared with $49.36 million a year earlier.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Enterprise Value (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Atossa Therapeutics' Enterprise Value came in at -$131.7 million; for FY2025, it came in at $34.91 million, down 30.7% from FY2024.
- By year, Enterprise Value came in at $50.34 million in FY2024 (+130.8%), $21.81 million in FY2023, -$43.78 million in FY2022 and -$136.19 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Enterprise Value since Q1 2023.
- Year over year, Enterprise Value gained in 1 of the last six quarters, with an average decline of 16.4%.
- The high point for year-over-year Enterprise Value in five years was Q2 2023 (growth of 380.5%); the low point was Q2 2022 (a decline of 98.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $13.58 million (Q1 2026), $34.91 million (Q4 2025) and $60.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Atossa Therapeutics | 19.96 Mn | -131.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.84 Mn |
| Mar 31, 2026 | 13.58 Mn |
| Dec 31, 2025 | 34.91 Mn |
| Sep 30, 2025 | 60.54 Mn |
| Jun 30, 2025 | 49.36 Mn |
| Mar 31, 2025 | 21.43 Mn |
| Dec 31, 2024 | 50.34 Mn |
| Sep 30, 2024 | 115.71 Mn |
| Jun 30, 2024 | 69.59 Mn |
| Mar 31, 2024 | 141.97 Mn |
| Dec 31, 2023 | 21.81 Mn |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | 60.01 Mn |
| Mar 31, 2023 | -12.69 Mn |
| Dec 31, 2022 | -43.78 Mn |
| Sep 30, 2022 | -12.26 Mn |
| Jun 30, 2022 | 12.49 Mn |
| Mar 31, 2022 | 26.80 Mn |
| Dec 31, 2021 | -136.19 Mn |
| Sep 30, 2021 | 272.77 Mn |
API Access
Atossa Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();